You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR SONIDEGIB PHOSPHATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for SONIDEGIB PHOSPHATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02303041 ↗	Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma	Terminated	National Cancer Institute (NCI)	Phase 2	2015-02-01	This pilot trial studies how well sonidegib and buparlisib work in treating patients with basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
NCT02303041 ↗	Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma	Terminated	Novartis Pharmaceuticals	Phase 2	2015-02-01	This pilot trial studies how well sonidegib and buparlisib work in treating patients with basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
NCT02303041 ↗	Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma	Terminated	Anne Chang	Phase 2	2015-02-01	This pilot trial studies how well sonidegib and buparlisib work in treating patients with basal cell carcinoma that has spread to other places in the body. Sonidegib and buparlisib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for SONIDEGIB PHOSPHATE

Condition Name

Chart
Table

Condition Name for SONIDEGIB PHOSPHATE
Intervention	Trials
Carcinoma, Basal Cell	2
Basal Cell Carcinoma of the Skin	1
Basal Cell Nevus Syndrome	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for SONIDEGIB PHOSPHATE
Intervention	Trials
Carcinoma	2
Carcinoma, Basal Cell	2
Basal Cell Nevus Syndrome	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for SONIDEGIB PHOSPHATE

Trials by Country

Map
Table

Trials by Country for SONIDEGIB PHOSPHATE
Location	Trials
United States	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for SONIDEGIB PHOSPHATE
Location	Trials
California	2
Virginia	1
Texas	1
New York	1
Florida	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for SONIDEGIB PHOSPHATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for SONIDEGIB PHOSPHATE
Clinical Trial Phase	Trials
Phase 2	1
Phase 1	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for SONIDEGIB PHOSPHATE
Clinical Trial Phase	Trials
Recruiting	1
Terminated	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SONIDEGIB PHOSPHATE

Sponsor Name

Chart
Table

Sponsor Name for SONIDEGIB PHOSPHATE
Sponsor	Trials
National Cancer Institute (NCI)	1
Novartis Pharmaceuticals	1
Anne Chang	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for SONIDEGIB PHOSPHATE
Sponsor	Trials
Industry	2
NIH	1
Other	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.